APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eosinophilic Esophagitis Drug

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

Selected research

Industry Growth & Trends

Global Eosinophilic Esophagitis Drug Industry Growth and Trends Forecast to 2032

25 December 2025104 pages

Choose your research edition.

Industry ResearchEosinophilic Esophagitis Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Eosinophilic Esophagitis Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Eosinophilic Esophagitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eosinophilic Esophagitis Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Eosinophilic Esophagitis Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

Read the full market overview

AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.

North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.

Report Scope

This report provides a structured, data-driven view of the global Eosinophilic Esophagitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Eosinophilic Esophagitis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Eosinophilic Esophagitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Eosinophilic Esophagitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Eosinophilic Esophagitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Eosinophilic Esophagitis Drug Market by Company

AstraZeneca

GSK

Bayer

Adare Pharmaceuticals

DBV Technologies

Dr. Falk Pharma

Quorum Innovations

Takeda

Calypso

Celgene

Regeneron

Eosinophilic Esophagitis Drug Segment by Type

Budesonide

Fluticasone

Others

Eosinophilic Esophagitis Drug Segment by Application

Hospitals

Clinics

Drugstore

Eosinophilic Esophagitis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eosinophilic Esophagitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eosinophilic Esophagitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eosinophilic Esophagitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eosinophilic Esophagitis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Eosinophilic Esophagitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Budesonide Table 2. Major Company of Fluticasone Table 3. Major Company of Others Table 4. Global Eosinophilic Esophagitis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Eosinophilic Esophagitis Drug Price by Type (2021-2026) & (USD/Unit) Table 10. Global Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Eosinophilic Esophagitis Drug Price by Type (2027-2032) & (USD/Unit) Table 15. North America Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Eosinophilic Esophagitis Drug Industry Trends Table 26. Eosinophilic Esophagitis Drug Industry Drivers Table 27. Eosinophilic Esophagitis Drug Industry Opportunities and Challenges Table 28. Eosinophilic Esophagitis Drug Industry Restraints Table 29. Global Eosinophilic Esophagitis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2021-2026) Table 31. Global Eosinophilic Esophagitis Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Eosinophilic Esophagitis Drug Sales Share by Company (2021-2026) Table 33. Global Eosinophilic Esophagitis Drug Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Eosinophilic Esophagitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Eosinophilic Esophagitis Drug Major Company Production Sites and Headquarters Table 36. Global Eosinophilic Esophagitis Drug Company, Product Type & Application Table 37. Global Eosinophilic Esophagitis Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Eosinophilic Esophagitis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Eosinophilic Esophagitis Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Eosinophilic Esophagitis Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Eosinophilic Esophagitis Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Eosinophilic Esophagitis Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Eosinophilic Esophagitis Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Eosinophilic Esophagitis Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Eosinophilic Esophagitis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Eosinophilic Esophagitis Drug Price by Application (2021-2026) & (USD/Unit) Table 57. Global Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Eosinophilic Esophagitis Drug Price by Application (2027-2032) & (USD/Unit) Table 62. North America Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Eosinophilic Esophagitis Drug Product Portfolio Table 76. AstraZeneca Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. GSK Eosinophilic Esophagitis Drug Product Portfolio Table 81. GSK Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Bayer Eosinophilic Esophagitis Drug Product Portfolio Table 86. Bayer Recent Development Table 87. Adare Pharmaceuticals Company Information Table 88. Adare Pharmaceuticals Business Overview Table 89. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolio Table 91. Adare Pharmaceuticals Recent Development Table 92. DBV Technologies Company Information Table 93. DBV Technologies Business Overview Table 94. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. DBV Technologies Eosinophilic Esophagitis Drug Product Portfolio Table 96. DBV Technologies Recent Development Table 97. Dr. Falk Pharma Company Information Table 98. Dr. Falk Pharma Business Overview Table 99. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolio Table 101. Dr. Falk Pharma Recent Development Table 102. Quorum Innovations Company Information Table 103. Quorum Innovations Business Overview Table 104. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolio Table 106. Quorum Innovations Recent Development Table 107. Takeda Company Information Table 108. Takeda Business Overview Table 109. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Takeda Eosinophilic Esophagitis Drug Product Portfolio Table 111. Takeda Recent Development Table 112. Calypso Company Information Table 113. Calypso Business Overview Table 114. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Calypso Eosinophilic Esophagitis Drug Product Portfolio Table 116. Calypso Recent Development Table 117. Celgene Company Information Table 118. Celgene Business Overview Table 119. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Celgene Eosinophilic Esophagitis Drug Product Portfolio Table 121. Celgene Recent Development Table 122. Regeneron Company Information Table 123. Regeneron Business Overview Table 124. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Regeneron Eosinophilic Esophagitis Drug Product Portfolio Table 126. Regeneron Recent Development Table 127. North America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 129. North America Eosinophilic Esophagitis Drug Sales Market Share by Country (2021-2026) Table 130. North America Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Eosinophilic Esophagitis Drug Sales Market Share Forecast by Country (2027-2032) Table 132. North America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Eosinophilic Esophagitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Eosinophilic Esophagitis Drug Market Share by Country (2021-2026) Table 135. North America Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Eosinophilic Esophagitis Drug Market Share Forecast by Country (2027-2032) Table 137. Europe Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 139. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country (2021-2026) Table 140. Europe Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Eosinophilic Esophagitis Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Eosinophilic Esophagitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Eosinophilic Esophagitis Drug Market Share by Country (2021-2026) Table 145. Europe Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Eosinophilic Esophagitis Drug Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Eosinophilic Esophagitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Eosinophilic Esophagitis Drug Market Share by Country (2021-2026) Table 155. Asia-Pacific Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Eosinophilic Esophagitis Drug Market Share Forecast by Country (2027-2032) Table 157. Latin America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 159. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country (2021-2026) Table 160. Latin America Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Eosinophilic Esophagitis Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Eosinophilic Esophagitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Eosinophilic Esophagitis Drug Market Share by Country (2021-2026) Table 165. Latin America Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Eosinophilic Esophagitis Drug Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Eosinophilic Esophagitis Drug Market Share by Country (2021-2026) Table 175. Middle East and Africa Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Eosinophilic Esophagitis Drug Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Eosinophilic Esophagitis Drug Distributors List Table 180. Eosinophilic Esophagitis Drug Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Eosinophilic Esophagitis Drug Image Figure 2. Global Eosinophilic Esophagitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eosinophilic Esophagitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Eosinophilic Esophagitis Drug Sales (2021-2032) & (K Units) Figure 5. Budesonide Image Figure 6. Global Budesonide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Fluticasone Image Figure 8. Global Fluticasone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Eosinophilic Esophagitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Eosinophilic Esophagitis Drug Market Share by Type 2025 VS 2032 Figure 13. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Eosinophilic Esophagitis Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Drugstore Image Figure 30. Global Drugstore Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Eosinophilic Esophagitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Eosinophilic Esophagitis Drug Market Share by Application 2025 VS 2032 Figure 33. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Eosinophilic Esophagitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Eosinophilic Esophagitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Eosinophilic Esophagitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Eosinophilic Esophagitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Eosinophilic Esophagitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Eosinophilic Esophagitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Eosinophilic Esophagitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Eosinophilic Esophagitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Eosinophilic Esophagitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Eosinophilic Esophagitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Eosinophilic Esophagitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Eosinophilic Esophagitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Eosinophilic Esophagitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Eosinophilic Esophagitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Eosinophilic Esophagitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Eosinophilic Esophagitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Eosinophilic Esophagitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Eosinophilic Esophagitis Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Eosinophilic Esophagitis Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Budesonide
  • Fluticasone
  • Others
Applications
  • Hospitals
  • Clinics
  • Drugstore
Companies covered
  • AstraZeneca
  • GSK
  • Bayer
  • Adare Pharmaceuticals
  • DBV Technologies
  • Dr. Falk Pharma
  • Quorum Innovations
  • Takeda
  • Calypso
  • Celgene
  • Regeneron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Eosinophilic Esophagitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Eosinophilic Esophagitis Drug Market by Type
  6. 1.3.1 Budesonide
  7. 1.3.2 Fluticasone
  8. 1.3.3 Others
  9. 1.4 Global Eosinophilic Esophagitis Drug Market Size by Type
  10. 1.4.1 Global Eosinophilic Esophagitis Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Eosinophilic Esophagitis Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Eosinophilic Esophagitis Drug Industry Trends
  2. 2.2 Eosinophilic Esophagitis Drug Industry Drivers
  3. 2.3 Eosinophilic Esophagitis Drug Industry Opportunities and Challenges
  4. 2.4 Eosinophilic Esophagitis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Eosinophilic Esophagitis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Eosinophilic Esophagitis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Eosinophilic Esophagitis Drug Price (2021-2026)
  4. 3.4 Global Eosinophilic Esophagitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eosinophilic Esophagitis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Eosinophilic Esophagitis Drug Company, Product Type & Application
  7. 3.7 Global Eosinophilic Esophagitis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eosinophilic Esophagitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eosinophilic Esophagitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eosinophilic Esophagitis Drug Tier 1, Tier 2, and Tier 3
4 Eosinophilic Esophagitis Drug Regional Status and Outlook
  1. 4.1 Global Eosinophilic Esophagitis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Eosinophilic Esophagitis Drug Historic Market Size by Region
  3. 4.2.1 Global Eosinophilic Esophagitis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Eosinophilic Esophagitis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Eosinophilic Esophagitis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Eosinophilic Esophagitis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Eosinophilic Esophagitis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Eosinophilic Esophagitis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Eosinophilic Esophagitis Drug by Application
  1. 5.1 Eosinophilic Esophagitis Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstore
  5. 5.2 Global Eosinophilic Esophagitis Drug Market Size by Application
  6. 5.2.1 Global Eosinophilic Esophagitis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Eosinophilic Esophagitis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Eosinophilic Esophagitis Drug Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Eosinophilic Esophagitis Drug Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Eosinophilic Esophagitis Drug Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Adare Pharmaceuticals
  20. 6.4.1 Adare Pharmaceuticals Company Information
  21. 6.4.2 Adare Pharmaceuticals Business Overview
  22. 6.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolio
  24. 6.4.5 Adare Pharmaceuticals Recent Developments
  25. 6.5 DBV Technologies
  26. 6.5.1 DBV Technologies Company Information
  27. 6.5.2 DBV Technologies Business Overview
  28. 6.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DBV Technologies Eosinophilic Esophagitis Drug Product Portfolio
  30. 6.5.5 DBV Technologies Recent Developments
  31. 6.6 Dr. Falk Pharma
  32. 6.6.1 Dr. Falk Pharma Company Information
  33. 6.6.2 Dr. Falk Pharma Business Overview
  34. 6.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolio
  36. 6.6.5 Dr. Falk Pharma Recent Developments
  37. 6.7 Quorum Innovations
  38. 6.7.1 Quorum Innovations Company Information
  39. 6.7.2 Quorum Innovations Business Overview
  40. 6.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolio
  42. 6.7.5 Quorum Innovations Recent Developments
  43. 6.8 Takeda
  44. 6.8.1 Takeda Company Information
  45. 6.8.2 Takeda Business Overview
  46. 6.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda Eosinophilic Esophagitis Drug Product Portfolio
  48. 6.8.5 Takeda Recent Developments
  49. 6.9 Calypso
  50. 6.9.1 Calypso Company Information
  51. 6.9.2 Calypso Business Overview
  52. 6.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Calypso Eosinophilic Esophagitis Drug Product Portfolio
  54. 6.9.5 Calypso Recent Developments
  55. 6.10 Celgene
  56. 6.10.1 Celgene Company Information
  57. 6.10.2 Celgene Business Overview
  58. 6.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Celgene Eosinophilic Esophagitis Drug Product Portfolio
  60. 6.10.5 Celgene Recent Developments
  61. 6.11 Regeneron
  62. 6.11.1 Regeneron Company Information
  63. 6.11.2 Regeneron Business Overview
  64. 6.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Regeneron Eosinophilic Esophagitis Drug Product Portfolio
  66. 6.11.5 Regeneron Recent Developments
7 North America by Country
  1. 7.1 North America Eosinophilic Esophagitis Drug Sales by Country
  2. 7.1.1 North America Eosinophilic Esophagitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Eosinophilic Esophagitis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Eosinophilic Esophagitis Drug Market Size by Country
  6. 7.2.1 North America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Eosinophilic Esophagitis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Eosinophilic Esophagitis Drug Sales by Country
  2. 8.1.1 Europe Eosinophilic Esophagitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Eosinophilic Esophagitis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Eosinophilic Esophagitis Drug Market Size by Country
  6. 8.2.1 Europe Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Eosinophilic Esophagitis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Eosinophilic Esophagitis Drug Sales by Country
  2. 10.1.1 South America Eosinophilic Esophagitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Eosinophilic Esophagitis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Eosinophilic Esophagitis Drug Market Size by Country
  6. 10.2.1 South America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Eosinophilic Esophagitis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Eosinophilic Esophagitis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Eosinophilic Esophagitis Drug Value Chain Analysis
  2. 12.1.1 Eosinophilic Esophagitis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Eosinophilic Esophagitis Drug Production Mode & Process
  7. 12.2 Eosinophilic Esophagitis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Eosinophilic Esophagitis Drug Distributors
  10. 12.2.3 Eosinophilic Esophagitis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst